Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06072560 is registered in ClinicalTrials.gov with Apurano Pharmaceuticals GmbH as lead sponsor.

NCT NCT06072560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06072560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
Lead sponsor
Apurano Pharmaceuticals GmbH
Phase
Phase 3
Overall status
Unknown status
Start date
November 2, 2023
Completion date
December 31, 2024
Enrollment
558 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, chronic pain, chronic pain syndrome, lower back pain, lower back pain chronic, pain, pain syndrome, pain, chronic